Cargando…
The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
HCV represents a global health problem with ~200 million individuals currently infected, worldwide. With the high cost of antiviral therapies, the global burden of chronic hepatitis C infection (CHCV) infection will be substantially reduced by the development of an effective vaccine for HCV. The fie...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674006/ https://www.ncbi.nlm.nih.gov/pubmed/29163442 http://dx.doi.org/10.3389/fmicb.2017.02163 |